Bioxytran Inc's Comment on Sales, Marketing and Customers
The company is a clinical-stage pharmaceutical firm engaged in the development, manufacturing, and commercialization of therapeutic drugs addressing unmet medical needs in viral infections, glycovirology, oxygen delivery, hypoxia, and degenerative diseases. Its product portfolio includes ProLectin-M for mild to moderate Covid-19 cases, ProLectin-I for severe Covid-19 cases, ProLectin-F for lung fibrosis associated with ventilator use in Covid-19 treatment, and ProLectin-A for acute respiratory distress syndrome (ARDS) caused by Covid-19. These treatments may also be applicable to other viral infections such as influenza. The company focuses on managing complications arising from Covid-19, including ARDS, shock, kidney failure, acute cardiac injury, and secondary bacterial infections linked to cytokine storms and systemic inflammatory responses leading to organ damage.
Bioxytran Inc’s Comment on Sales, Marketing and Customers
The company is a clinical-stage pharmaceutical firm engaged in the development, manufacturing, and commercialization of therapeutic drugs addressing unmet medical needs in viral infections, glycovirology, oxygen delivery, hypoxia, and degenerative diseases. Its product portfolio includes ProLectin-M for mild to moderate Covid-19 cases, ProLectin-I for severe Covid-19 cases, ProLectin-F for lung fibrosis associated with ventilator use in Covid-19 treatment, and ProLectin-A for acute respiratory distress syndrome (ARDS) caused by Covid-19. These treatments may also be applicable to other viral infections such as influenza. The company focuses on managing complications arising from Covid-19, including ARDS, shock, kidney failure, acute cardiac injury, and secondary bacterial infections linked to cytokine storms and systemic inflammatory responses leading to organ damage.
Sources:
Bioxytran Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Bioxytran Inc’s corporate clients.
For your research, we’ve provided 9 tables on Bioxytran Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
